Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency

Front Immunol. 2022 Aug 26:13:1010072. doi: 10.3389/fimmu.2022.1010072. eCollection 2022.

Authors

Antonio Condino-Neto¹, Andrew R Gennery^{2

3}

Affiliations

¹ Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
² Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
³ Paediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.

No abstract available

Keywords: antibody defects; cellular defects; combined immunodeficiencies; predominantly antibody deficiencies; treatment challenges.

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal* / therapeutic use
Communicable Diseases*
Humans
Immunotherapy
Plasma

Substances

Antibodies, Monoclonal